Nutrition and developmental biology - Implications for public health

Nutrition Reviews

Volumn 64, Issue 5 SUPPL. 1, 2006, Pages

  Stover, Patrick J ^a   Garza, Cutberto ^b  

^a Department of Obstetrics Gynecology   (United States)

^b BOSTON COLLEGE   (United States)

Author keywords

Developmental biology; Gene nutrient interactions; Public health

Indexed keywords

GLYCINE HYDROXYMETHYLTRANSFERASE; FOLIC ACID;

BIRTH DEFECT; CANCER; CANCER RISK; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHRONIC DISEASE; CONGENITAL MALFORMATION; DEVELOPMENTAL BIOLOGY; DIET; DNA REPLICATION; EPIGENETICS; GENE FUNCTION; GENE INTERACTION; GENOME; GENOME ANALYSIS; GENOTYPE; HEALTH CARE; HUMAN; MATERNAL NUTRITION; MORPHOGENESIS; NONHUMAN; NUTRITION; PREGNANCY OUTCOME; REVIEW; SPONTANEOUS ABORTION; ANIMAL; EMBRYO DEVELOPMENT; ENVIRONMENT; EVOLUTION; FEMALE; GENETIC EPIGENESIS; GENETIC SELECTION; GENETICS; GROWTH, DEVELOPMENT AND AGING; PHYSIOLOGY; PREGNANCY; PUBLIC HEALTH; REPRODUCTION; SACCHAROMYCES CEREVISIAE;

ANIMALIA;

ANIMALS; DEVELOPMENTAL BIOLOGY; DIET; EMBRYONIC DEVELOPMENT; ENVIRONMENT; EPIGENESIS, GENETIC; EVOLUTION; FEMALE; FOLIC ACID; GENETICS; GLYCINE HYDROXYMETHYLTRANSFERASE; HUMANS; MATERNAL NUTRITION PHYSIOLOGY; NUTRITION PHYSIOLOGY; PREGNANCY; PUBLIC HEALTH; REPRODUCTION; SACCHAROMYCES CEREVISIAE; SELECTION (GENETICS);

EID: 33745498317     PISSN: 00296643     EISSN: 00296643     Source Type: Journal    
DOI: 10.1301/nr.2006.may.S60-S71     Document Type: Review

References (119)

1. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, et al. The sequence of the human genome. Science. 2001;291:1304-1351.
2. Stover PJ. Nutritional genomics. Physiol Genomics. 2004;16:161-165.
3. Stover PJ, Garza C. Bringing individuality to public health recommendations. J Nutr. 2002;132(8 suppl):2476S-2480S.
4. Morohashi M, Winn AE, Borisuk MT, Bolouri H, Doyle J, Kitano H. Robustness as a measure of plausibility in models of biochemical networks. J Theor Biol. 2002;216:19-30.
5. Greenspan RJ. The flexible genome. Nat Rev Genet. 2001;2:383-387.
6. Pal C, Papp B, Hurst LD. Genomic function: Rate of evolution and gene dispensability. Nature. 2003;421:496-498.
7. Giaever G, Chu AM, Ni L, Connelly C, Riles L, Veronneau S, et al. Functional profiling of the Saccharomyces cerevisiae genome. Nature. 2002;418:387-391.
8. Gasch AP, Werner-Washburne M. The genomics of yeast responses to environmental stress and starvation. Funct Integr Genomics. 2002;2:181-192.
9. Gasch AP, Spellman PT, Kao CM, et al. Genomic expression programs in the response of yeast cells to environmental changes. Mol Biol Cell. 2000;11:4241-4257.
10. Albert R, Jeong H, Barabasi AL. Error and attack tolerance of complex networks. Nature. 2000;406:378-382.
11. Delhanty JD. Preimplantation genetics: an explanation for poor human fertility? Ann Hum Genet. 2001;65(part 4):331-338.
12. Brent RL, Beckman DA. The contribution of environmental teratogens to embryonic and fetal loss. Clin Obstet Gynecol. 1994;37:646-670.
13. Edmonds DK, Lindsay KS, Miller JF, Williamson E, Wood PJ. Early embryonic mortality in women. Fertil Steril. 1982;38:447-453.
14. Edwards RG. Recent scientific and medical advances in assisted human conception. Int J Dev Biol. 1997;41:255-262.
15. Wilcox AJ, Weinberg CR, O'Connor JF, et al. Incidence of early loss of pregnancy. N Engl J Med. 1988;319:189-194.
16. Bulletti C, Flamigni C, Giacomucci E. Reproductive failure due to spontaneous abortion and recurrent miscarriage. Hum Reprod Update. 1996;2:118-136.
17. Brock DJ, Holloway S. Fertility of older women. Lancet. 1990;335:1470.
18. Cowchock FS, Gibas Z, Jackson LG. Chromosome errors as a cause of spontaneous abortion: the relative importance of maternal age and obstetric history. Fertil Steril. 1993;59:1011-1014.
19. Gris JC, Perneger TV, Quere I, et al. Antiphospholipid/antiprotein antibodies, hemostasis-related autoantibodies, and plasma homocysteine as risk factors for a first early pregnancy loss: a matched case-control study. Blood. 2003;102:3504-3513.
20. Zetterberg H. Methylenetetrahydrofolate reductase and transcobalamin genetic polymorphisms in human spontaneous abortion: biological and clinical implications. Reprod Biol Endocrinol. 2004;2:7.
21. Zetterberg H, Regland B, Palmer M, et al. Increased frequency of combined methylenetetrahydrofolate reductase C677T and A1298C mutated alleles in spontaneously aborted embryos. Eur J Hum Genet. 2002;10:113-118.
22. Zetterberg H, Regland B, Palmer M, et al. The transcobalamin codon 259 polymorphism influences the risk of human spontaneous abortion. Hum Reprod. 2002;17:3033-3036.
23. Zetterberg H, Zafiropoulos A, Spandidos DA, Rymo L, Blennow K. Gene-gene interaction between fetal MTHFR 677C→T and transcobalamin 776C3G polymorphisms in human spontaneous abortion. Hum Reprod. 2003;18:1948-1950.
24. Nelen WL, Blom HJ, Steegers EA, den Heijer M, Eskes TK. Hyperhomocysteinemia and recurrent early pregnancy loss: a meta-analysis. Fertil Steril. 2000;74:1196-1199.
25. Nelen WL. Hyperhomocysteinaemia and human reproduction. Clin Chem Lab Med. 2001;39:758-763.
26. Isotalo PA, Wells GA, Donnelly JG. Neonatal and fetal methylenetetrahydrofolate reductase genetic polymorphisms: an examination of C677T and A1298C mutations. Am J Hum Genet. 2000;67:986-990.
27. Brody LC, Conley M, Cox C, et al. A polymorphism, R653Q, in the trifunctional enzyme methylenetetrahydrofolate dehydrogenase/ methenyltetrahydrofolate cyclohydrolase/formyltetrahydrofolate synthetase is a maternal genetic risk factor for neural tube defects: Report of the Birth Defects Research Group. Am J Hum Genet. 2002;71:1207-1215.
28. Nelen WL, Blom HJ, Steegers EA, den Heijer M, Thomas CM, Eskes TK. Homocysteine and folate levels as risk factors for recurrent early pregnancy loss. Obstet Gynecol. 2000;95:519-524.
29. Nelen WL, Blom HJ, Thomas CM, Steegers EA, Boers GH, Eskes TK. Methylenetetrahydrofolate reductase polymorphism affects the change in homocysteine and folate concentrations resulting from low dose folic acid supplementation in women with unexplained recurrent miscarriages. J Nutr. 1998;128:1336-1341.
30. Akey JM, Eberle MA, Rieder MJ, et al. Population history and natural selection shape patterns of genetic variation in 132 genes. PLoS Biol. 2004;2:e286.
31. Wooding S. Natural selection: sign, sign, everywhere a sign. Curr Biol. 2004;14:R700-R701.
32. Wooding S. PopHist: inferring population history from the spectrum of allele frequencies. Bioinformatics. 2003;19:539-540.
33. Jorde LB, Watkins WS, Bamshad MJ, et al. The distribution of human genetic diversity: a comparison of mitochondrial, autosomal, and Y-chromosome data. Am J Hum Genet. 2000;66:979-988.
34. Jorde LB, Wooding SP. Genetic variation, classification and "race." Nat Genet. 2004;36(11 suppl):S28-S33.
35. Clark AG, Glanowski S, Nielsen R, et al. Inferring nonneutral evolution from human-chimp-mouse orthologous gene trios. Science. 2003;302:1960-1963.
36. Bamshad M, Wooding SP. Signatures of natural selection in the human genome. Nat Rev Genet. 2003;4:99-111.
37. Akey JM, Zhang G, Zhang K, Jin L, Shriver MD. Interrogating a high-density SNP map for signatures of natural selection. Genome Res. 2002;12:1805-1814.
38. Poulter M, Hollox E, Harvey CB, et al. The causal element for the lactase persistence/non-persistence polymorphism is located in a 1 Mb region of linkage disequilibrium in Europeans. Ann Hum Genet. 2003;67(part 4):298-311.
39. Enattah NS, Sahi T, Savilahti E, Terwilliger JD, Peltonen L, Jarvela I. Identification of a variant associated with adult-type hypolactasia. Nat Genet. 2002;30:233-237.
40. Bersaglieri T, Sabeti PC, Patterson N, et al. Genetic signatures of strong recent positive selection at the lactase gene. Am J Hum Genet. 2004;74:1111-1120.
41. Toomajian C, Ajioka RS, Jorde LB, Kushner JP, Kreitman M. A method for detecting recent selection in the human genome from allele age estimates. Genetics. 2003;165:287-297.
42. Toomajian C, Kreitman M. Sequence variation and haplotype structure at the human HFE locus. Genetics. 2002;161:1609-1623.
43. Beutler E. Iron absorption in carriers of the C282Y hemochromatosis mutation. Am J Clin Nutr. 2004;80:799-800.
44. Osier MV, Pakstis AJ, Soodyall H, et al. A global perspective on genetic variation at the ADH genes reveals unusual patterns of linkage disequilibrium and diversity. Am J Hum Genet. 2002;71:84-99.
45. Loew M, Boeing H, Sturmer T, Brenner H. Relation among alcohol dehydrogenase 2 polymorphism, alcohol consumption, and levels of gamma-glutamyltransferase. Alcohol. 2003;29:131-135.
46. Ma J, Stampfer MJ, Giovannucci E, et al. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res. 1997;57:1098-1102.
47. Bailey LB. Folate, methyl-related nutrients, alcohol, and the MTHFR 677C→T polymorphism affect cancer risk: intake recommendations. J Nutr. 2003;133(11 suppl 1):3748S-3753S.
48. Guenther BD, Sheppard CA, Tran P, Rozen R, Matthews RG, Ludwig ML. The structure and properties of methylenetetrahydrofolate reductase from Escherichia coli suggest how folate ameliorates human hyperhomocysteinemia. Nat Struct Biol. 1999;6:359-365.
49. Nelson RL, Persky V, Davis F, Becker E. Is hereditary hemochromatosis a balanced polymorphism? An analysis of family size among hemochromatosis heterozygotes. Hepatogastroenterology. 2001;48:523-526.
50. Neel JV. Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? Am J Hum Genet. 1962;14:353-362.
51. Diamond J. The double puzzle of diabetes. Nature. 2003;423:599-602.
52. Waterland RA, Garza C. Potential mechanisms of metabolic imprinting that lead to chronic disease. Am J Clin Nutr. 1999;69:179-197.
53. Ruden DM, Garfinkel MD, Sollars VE, Lu X. Waddington's widget: Hsp90 and the inheritance of acquired characters. Semin Cell Dev Biol. 2003;14:301-310.
54. Ruden DM, Xiao L, Garfinkel MD, Lu X. Hsp90 and environmental impacts on epigenetic states: a model for the trans-generational effects of diethylstibesterol on uterine development and cancer. Hum Mol Genet. 2005;14(suppl 1):R149-R155.
55. Milton CC, Huynh B, Batterham P, Rutherford SL, Hoffmann AA. Quantitative trait symmetry independent of Hsp90 buffering: distinct modes of genetic canalization and developmental stability. Proc Natl Acad Sci U S A. 2003;100:13396-13401.
56. Gibson G, Wagner G. Canalization in evolutionary genetics: a stabilizing theory? Bioessays. 2000;22:372-380.
57. Siegal ML, Bergman A. Waddington's canalization revisited: developmental stability and evolution. Proc Natl Acad Sci U S A. 2002;99:10528-10532.
58. Davey Smith G, Ebrahim S. "Mendelian randomization": can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003;32:1-22.
59. Rutherford SL. From genotype to phenotype: buffering mechanisms and the storage of genetic information. Bioessays. 2000;22:1095-1105.
60. Rutherford SL, Lindquist S. Hsp90 as a capacitor for morphological evolution. Nature. 1998;396:336-342.
61. Queitsch C, Sangster TA, Lindquist S. Hsp90 as a capacitor of phenotypic variation. Nature. 2002;417:618-624.
62. Stover PJ. Physiology of folate and vitamin B12 in health and disease. Nutr Rev. 2004;62(6 part 2):S3-S13.
63. Suh JR, Herbig AK, Stover PJ. New perspectives on folate catabolism. Annu Rev Nutr. 2001;21:255-282.
64. Blount BC, Mack MM, Wehr CM, et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci U S A. 1997;94:3290-3295.
65. Clarke S, Banfield K. S-adenosylmethionine-dependent methyltransferases. In: Carmel R, Jacobson DW, eds. Homocysteine in Health and Disease. Cambridge, UK: Cambridge University Press; 2001.
66. Finkelstein JD. Homocysteine: a history in progress. Nutr Rev. 2000;58:193-204.
67. Finkelstein JD. Pathways and regulation of homocysteine metabolism in mammals. Semin Thromb Hemost. 2000;26:219-225.
68. Choi SW, Mason JB. Folate and carcinogenesis: an integrated scheme. J Nutr. 2000;130:129-132.
69. Oyama K, Kawakami K, Maeda K, Ishiguro K, Watanabe G. The association between methylenetetrahydrofolate reductase polymorphism and promoter methylation in proximal colon cancer. Anticancer Res. 2004;24:649-654.
70. Shelnutt KP, Kauwell GP, Gregory JF 3rd, et al. Methylenetetrahydrofolate reductase 677C→T polymorphism affects DNA methylation in response to controlled folate intake in young women. J Nutr Biochem. 2004;15:554-560.
71. Quinlivan EP, Davis SR, Shelnutt KP, et al. Methylenetetrahydrofolate reductase 677C→T polymorphism and folate status affect one-carbon incorporation into human DNA deoxynucleosides. J Nutr. 2005;135:389-396.
72. Zanetti KA, Stover PJ. Pyridoxal phosphate inhibits dynamic subunit interchange among serine hydroxymethyltransferase tetramers. J Biol Chem. 2003;278:10142-10149.
73. Zingg JM, Jones PA. Genetic and epigenetic aspects of DNA methylation on genome expression, evolution, mutation and carcinogenesis. Carcinogenesis. 1997;18:869-882.
74. Mason JB, Kim Y. Nutritional strategies in the prevention of colorectal cancer. Curr Gastroenterol Rep. 1999;1:341-353.
75. Kim M, Trinh BN, Long TI, Oghamian S, Laird PW. Dnmt1 deficiency leads to enhanced microsatellite instability in mouse embryonic stem cells. Nucleic Acids Res. 2004;32:5742-5749.
76. Ingrosso D, Cimmino A, Perna AF, et al. Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia. Lancet. 2003;361:1693-1699.
77. Petry CJ, Ong KK, Barratt BJ, et al. Common polymorphism in H19 associated with birthweight and cord blood IGF-II levels in humans. BMC Genet. 2005;6:22.
78. Waterland RA, Jirtle RL. Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. Nutrition. 2004;20:63-68.
79. Waterland RA, Jirtle RL. Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol. 2003;23:5293-5300.
80. Waterland RA, Shi X, Lin, JR, Smith CA. Nutritional epigenetics in axin-fused (Axin[fu]) mice: kinky "tales" about mom's diet [abstract]. In: Proceedings of the Federation of American Societies for Experimental Biology Conference. Part I (abstract 161.2); 2005; A218-A219.
81. Herbig K, Chiang EP, Lee LR, Hills J, Shane B, Stover PJ. Cytoplasmic serine hydroxymethyltransferase mediates competition between folate-dependent deoxyribonucleotide and S-adenosylmethionine biosyntheses. J Biol Chem. 2002;277:38381-38389.
82. Perry C, Sastry R, Nasrallah IM, Stover PJ. Mimosine attenuates serine hydroxymethyltransferase transcription by chelating zinc: implications for inhibition of DNA replication. J Biol Chem. 2005;280:396-400.
83. Oppenheim EW, Adelman C, Liu X, Stover PJ. Heavy chain ferritin enhances serine hydroxymethyltransferase expression and de novo thymidine biosynthesis. J Biol Chem. 2001;276:19855-19861.
84. Girgis S, Nasrallah IM, Suh JR, et al. Molecular cloning, characterization and alternative splicing of the human cytoplasmic serine hydroxymethyltransferase gene. Gene. 1998;210:315-324.
85. Lim U, Peng K, Shane B, et al. Polymorphisms in cytoplasmic serine hydroxymethyltransferase and methylenetetrahydrofolate reductase affect the risk of cardiovascular disease in men. J Nutr. 2005;135:1989-1994.
86. Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong LY. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA. 2001;285:2981-2986.
87. Delange FM. Control of iodine deficiency in western and central Europe. Cent Eur J Public Health. 2003;11:120-123.
88. Centers for Disease Control and Prevention (CDC). Alcohol consumption among women who are pregnant or who might become pregnant - United States, 2002. MMWR Morb Mortal Wkly Rep. 2004;53:1178-1181.
89. Swanson CA. Iron intake and regulation: implications for iron deficiency and iron overload. Alcohol. 2003;30:99-102.
90. Mellott TJ, Williams CL, Meck WH, Blusztajn JK. Prenatal choline supplementation advances hippocampal development and enhances MAPK and CREB activation. FASEB J. 2004;18:545-547.
91. Heird WC, Lapillonne A. The role of essential fatty acids in development. Annu Rev Nutr. 2005;25:549-571.
92. Stillman RJ, Rosenberg MJ, Sachs BP. Smoking and reproduction. Fertil Steril. 1986;46:545-566.
93. De Rycke M, Liebaers I, Van Steirteghem A. Epigenetic risks related to assisted reproductive technologies: risk analysis and epigenetic inheritance. Hum Reprod. 2002;17:2487-2494.
94. Sinclair KD, Dunne LD, Maxfield EK, et al. Fetal growth and development following temporary exposure of day 3 ovine embryos to an advanced uterine environment. Reprod Fertil Dev. 1998;10:263-269.
95. Young LE, Fernandes K, McEvoy TG, et al. Epigenetic change in IGF2R is associated with fetal overgrowth after sheep embryo culture. Nat Genet. 2001;27:153-154.
96. Khosla S, Dean W, Reik W, Feil R. Culture of preimplantation embryos and its long-term effects on gene expression and phenotype. Hum Reprod Update. 2001;7:419-427.
97. Gao S, Latham KE. Maternal and environmental factors in early cloned embryo development. Cytogenet Genome Res. 2004;105:279-284.
98. Weaver IC, Cervoni N, Champagne FA, et al. Epigenetic programming by maternal behavior. Nat Neurosci. 2004;7:847-854.
99. Weaver IC, Diorio J, Seckl JR, Szyf M, Meaney MJ. Early environmental regulation of hippocampal glucocorticoid receptor gene expression: characterization of intracellular mediators and potential genomic target sites. Ann N Y Acad Sci. 2004;1024:182-212.
100. Thomassin H, Flavin M, Espinas ML, Grange T. Glucocorticoid-induced DNA demethylation and gene memory during development. Embo J. 2001;20:1974-1983.
101. Pennisi E. Evolution of developmental diversity. Evo-devo devotees eye ocular origins and more. Science. 2002;296:1010-1011.
102. Pasqualetti M, Neun R, Davenne M, Rijli FM. Retinoic acid rescues inner ear defects in Hoxa1 deficient mice. Nat Genet. 2001;29:34-39.
103. Zhao R, Russell RG, Wang Y, et al. Rescue of embryonic lethality in reduced folate carrier-deficient mice by maternal folic acid supplementation reveals early neonatal failure of hematopoietic organs. J Biol Chem. 2001;276:10224-10228.
104. Finnell RH, Spiegelstein O, Wlodarczyk B, et al. DNA methylation in Folbp1 knockout mice supplemented with folic acid during gestation. J Nutr. 2002;132(8 suppl):2457S-2461S.
105. Munoz-Moran E, Dieguez-Lucena JL, Fernandez-Arcas N, Peran-Mesa S, Reyes-Engel A. Genetic selection and folate intake during pregnancy. Lancet. 1998;352:1120-1121.
106. Reyes-Engel A, Munoz E, Gaitan MJ, et al. Implications on human fertility of the 677C→T and 1298A→C polymorphisms of the MTHFR gene: consequences of a possible genetic selection. Mol Hum Reprod. 2002;8:952-957.
107. Whitehead AS. Changes in MTHFR genotype frequencies over time. Lancet. 1998;352:1784-1785.
108. Bailey LB, Gregory JF 3rd. Folate metabolism and requirements. J Nutr. 1999;129:779-782.
109. von Linsingen R, Bompeixe EP, Bicalho Mda G. A case-control study in IL6 and TGFB1 gene polymorphisms and recurrent spontaneous abortion in southern Brazilian patients. Am J Reprod Immunol. 2005;53:94-99.
110. Prigoshin N, Tambutti M, Larriba J, Gogorza S, Testa R. Cytokine gene polymorphisms in recurrent pregnancy loss of unknown cause. Am J Reprod Immunol. 2004;52:36-41.
111. Daher S, Shulzhenko N, Morgun A, et al. Associations between cytokine gene polymorphisms and recurrent pregnancy loss. J Reprod Immunol. 2003;58:69-77.
112. Perni SC, Vardhana S, Tuttle SL, Kalish RB, Chasen ST, Witkin SS. Fetal interleukin-1 receptor antagonist gene polymorphism, intra-amniotic interleukin-1beta levels, and history of spontaneous abortion. Am J Obstet Gynecol. 2004;191:1318-1323.
113. Sata F, Yamada H, Yamada A, et al. A polymorphism in the CYP17 gene relates to the risk of recurrent pregnancy loss. Mol Hum Reprod. 2003;9:725-728.
114. Suryanarayana V, Deenadayal M, Singh L. Association of CYP1A1 gene polymorphism with recurrent pregnancy loss in the South Indian population. Hum Reprod. 2004;19:2648-2652.
115. Schweikert A, Rau T, Berkholz A, Allera A, Daufeldt S, Wildt L. Association of progesterone receptor polymorphism with recurrent abortions. Eur J Obstet Gynecol Reprod Biol. 2004;113:67-72.
116. Sata F, Yamada H, Kondo T, et al. Glutathione S-transferase M1 and T1 polymorphisms and the risk of recurrent pregnancy loss. Mol Hum Reprod. 2003;9:165-169.
117. Finan RR, Tamim H, Ameen G, Sharida HE, Rashid M, Almawi WY. Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population. Am J Hematol. 2002;71:300-305.
118. Tempfer C, Unfried G, Zeillinger R, Hefler L, Nagele F, Huber JC. Endothelial nitric oxide synthase gene polymorphism in women with idiopathic recurrent miscarriage. Hum Reprod. 2001;16:1644-1647.
119. Gloria-Bottini F, Lucarini N, Palmarino R, et al. Phosphoglucomutase genetic polymorphism of newborns. Am J Hum Biol. 2001;13:9-14.